Healy and Civil Aviation Safety Authority

Link copied
Case Copied 59 min read

Healy and Civil Aviation Safety Authority [2017] AATA 741 (19 May 2017)

Division:GENERAL DIVISION

File Number:           2016/6064

Re:Daniel Healy

APPLICANT

AndCivil Aviation Safety Authority

RESPONDENT

DECISION

Tribunal:Deputy President Dr Christopher Kendall

Date:19 May 2017

Place:Perth

The decision under review is affirmed.

.........................[sgd].................................

Deputy President Dr Christopher Kendall

CATCHWORDS

CIVIL AVIATION – Class 1 and Class 2 medical standards – risk to the safety of air navigation – whether conditions can be issued that ameliorate any risk posed – Attention Deficit Hyperactivity Disorder – use of Dexamphetamine to control condition – decision under review affirmed

LEGISLATION

Civil Aviation Act 1988 – sections 3(1), 9A, 20AB(1),
Civil Aviation Safety Regulations 1998 – regulations 11.056, 61.410, 61.415, 67.015, 67.150, 67.155, 67.180,

CASES
Re Hall and Civil Aviation Safety Authority [2004] AATA 21

Re Window v Civil Aviation Safety Authority (1999) 56 ALD 316

REASONS FOR DECISION

Deputy President Dr Christopher Kendall

19 May 2017

BACKGROUND

  1. Daniel Healy, age 30, wishes to obtain a Commercial Pilot Licence.  On 13 April 2016, Mr Healy applied for a Class 1 and Class 2 medical certificate from the Civil Aviation Safety Authority (“CASA”).  As part of that application process, Mr Healy undertook a medical examination by a Designated Aviation Medical Examiner (“DAME”), Dr Mary Cadden. 

  2. During this medical examination, Mr Healy stated that he was taking Dexamphetamine for the medical condition Attention Deficit Hyperactivity Disorder (“ADHD”).  A series of medical investigations occurred thereafter (discussed further below). 

  3. On 2 November 2016, a delegate for CASA refused to issue Mr Healy a Class 1 or a Class 2 medical certificate (the “Reviewable Decision”).  Relevantly, the delegate held:

    Due to your Attention Deficit Hyperactivity Disorder requiring medication, I have decided that you do not meet the above Class 1 and 2 Medical Standard.

    As you do not meet the Medical Standard, CASA may only grant you a Class 1 and 2 Medical Certificate if it is satisfied that, the extent to which you fail to meet the applicable medical is not likely to endanger the safety of air navigation.

    Risks to air safety

    Your medical condition is associated with a number of potential symptoms and side effects which may adversely affect your ability to safely exercise the privileges of your pilot licence including (but not limited to):

    •Premature and ill-considered actions

    •Restlessness and excess of movement causing distraction

    •Impaired split attention affecting multi-tasking and situational awareness

    •Side effects of medication (this list reflects some of the side effects, and is not complete)

    omood changes such as depression or irritability

    otremor or palpitations

    orestlessness, nervousness or insomnia

    oheadache

    odizziness

    Conditional Certificate

    I have decided that there is a real and substantial risk that your condition requiring treatment and their [sic] symptoms or side-effects will interfere with your ability to safely pilot aircraft and therefore create an unacceptable risk to the safety of air navigation. I have also concluded that no conditions imposed upon your medical certificate would…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Healy and Civil Aviation Safety Authority and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2017] AATA 741
Decision Date

CaseChat Overview and Summary

This matter concerned an appeal by Mr Healy against a decision by the Civil Aviation Safety Authority (CASA) to refuse him a Class 1 or Class 2 medical certificate. The central dispute revolved around Mr Healy's diagnosis of Attention Deficit Hyperactivity Disorder (ADHD) and his treatment with dexamphetamine. The Tribunal was required to determine whether Mr Healy met the relevant medical standards, and if not, whether his condition posed a risk to air navigation safety, and if so, whether any conditions could mitigate that risk.

The legal issues before the Tribunal were threefold. First, it had to ascertain whether Mr Healy met the prescribed medical standards for a Class 1 or Class 2 medical certificate. Second, if he did not meet these standards, the Tribunal was required to assess whether the extent of his failure was likely to endanger the safety of air navigation. Third, and crucially, if a risk to air safety was identified, the Tribunal had to determine whether any conditions could be imposed on a medical certificate that would effectively ameliorate that risk.

The Tribunal's reasoning was guided by section 9A of the Civil Aviation Act, which mandates that the safety of air navigation must be the paramount consideration. It found that Mr Healy did not meet the medical standards due to his established diagnosis of ADHD and his ongoing reliance on dexamphetamine. The Tribunal further determined that this failure to meet the standards was likely to endanger air navigation safety. Critically, after considering the nature of Mr Healy's condition and the medication used to manage it, the Tribunal concluded that no conditions could be imposed on a medical certificate that would sufficiently ameliorate the identified threat to air safety. Consequently, the Tribunal affirmed CASA's decision to refuse the medical certificate.

Background

Background to the litigation

Daniel Healy, a pilot, was diagnosed with Attention Deficit Hyperactivity Disorder (ADHD) in 2014 and has been treated with dexamphetamine to manage his condition. ADHD is a lifelong condition that affects Daniel's focus, efficiency, and ability to complete tasks effectively. While on medication, Daniel has shown significant improvement in his academic performance and aviation studies. The Civil Aviation Safety Authority (CASA) reviewed Daniel's case to determine if he meets the medical standards for a Class 1 or Class 2 medical certificate, which are necessary for him to legally operate an aircraft. CASA considered the risk that Daniel's condition and medication pose to the safety of air navigation.

The matter was heard by the Administrative Appeals Tribunal (AAT) on 30 March 2017 in Perth. Daniel Healy appeared self-represented, while CASA was represented by Ms Swain. The Tribunal reviewed various documents, including statements of facts, issues, and contentions, medical reports, and submissions from both parties. Oral evidence was also heard from Daniel, his treating psychiatrist Dr Roger Paterson, and other medical professionals. The Tribunal's decision was to affirm the original decision by CASA that Daniel does not meet the medical standards for a Class 1 or Class 2 medical certificate and that no conditions can be imposed to mitigate the risk he poses to air safety.

Evidence

Evidence Before The Court

As correctly outlined by CASA in a Statement of Facts, Issues and Contentions dated 17 March 2017, in determining whether Mr Healy should be issued a Class 1 or Class 2 medical certificate, the Tribunal must determine: a)whether Mr Healy meets the medical standard for the issue of a Class 1 or Class 2 medical certificate;b)if not, whether the extent to which Mr Healy fails to meet those standards is likely to endanger the safety of air navigation; andc)if so, whether any conditions can be imposed upon a medical certificate which will ameliorate the threat posed to air safety by Mr Healy’s failure to meet the Class 1 and Class 2 medical standard.EVIDENCE BEFORE THE TRIBUNAL This matter was heard in Perth on 30 March 2017. Mr Healy attended in person and was self-represented. CASA was represented by Ms Swain. The Tribunal had before it the following evidence:·A 163 page set of T-Documents (T1 to T53);·A Statement of Facts, Issues and Contentions from Mr Healy dated 16 January 2017;·A Statement of Facts, Issues and Contentions from the Authority dated 17 March 2017;·A document titled “Loss of Control and Collision with Terrain involving Cessna 182” dated 23 September 2013;·Independent Medico-Legal Report from Dr Benjamin Duke dated 3 October 1986;·Statement of Dr Sanjiv Kumar Sharma dated 17 March 2017 with attached medical journal articles;·Written Closing Submissions from CASA dated 30 March 2017; and·Written Closing Submissions from Mr Healy dated 12 April 2017. The Tribunal also heard oral evidence from Mr Healy, Dr Sharma, Dr Duke and Dr Paterson. CASA provided a detailed summary of the medical evidence in the T documents at paragraphs 7 to 14. Mr Healy did not dispute that summary. The Tribunal notes, relevantly, as follows in that regard. Dr Roger Paterson has been Mr Healy’s psychiatrist since early 2014. He diagnosed, and has treated, Mr Healy’s ADHD since that time. The Tribunal has reviewed the various letters from Dr Paterson outlining Mr Healy’s treatment with the medication dexamphetamine and Mr Healy’s positive response to that medication at T6, T7, T8, T9, T13 and T29. A report by Dr Paterson dated 16 July 2016 (T32) states:Daniel sees me annually for renewal of his medication for Attention Deficit Hyperactivity Disorder (ADHD) which is controlled with dexamphetamine (a mixture of immediate and slow release formulations).1.Onset of his condition: I first met him on the 14 February 2014 and diagnosed his ADHD at that time. As is typical, his condition was life-long, becoming a problem in early primary school when he was meant to be applying himself to his studies, but found this very difficult.2.Symptoms including any suicidal ideation, psychosis, mania or anxiety: He had the typical symptoms of ADHD: overactivity, impulsivity, inattention, distractability, disorganisation, emotional lability, stress intolerance, inefficiency and struggling to achieve full potential. There was no evidence of any suicidal ideation, psychosis, mania or anxiety.3.Psychosocial and functional impact on the condition: His ADHD caused problems both at home and at school/work. He found it difficult to complete tasks and function effectively. He was often in conflict with authority figures as he found it difficult to comply with rules and regulations. His academic performance in year 11 and 12 was poor; leaving high school without any distinction. That said, he enjoyed his aviation experience at his school which had a specialist aviation program (Greenwood SHS) and in fact did get his restricted pilot’s licence. This is typical of ADHD people – if they are interested in something, they can concentrate on it, often hyperfocusing. Unfortunately, subjects that are a little bit less interesting are ignored completely.’6.Treatment, response to treatment and side effects: After many years of struggling in the workplace without getting any qualifications, he eventually decided that he needed to get things sorted out. With treatment, he has made great advances, eventually passing a shift supervisor certificate. And he is doing well with his aviation studies over the last 6 months. He is currently on compounded dexamphetamine 25mg controlled release capsules, one daily, and very occasional dexamphetamine 5mg tablets as a top up/alternative. These improve his focus and general efficiency with no side-effects.7.DSM-5 diagnosis – detailing inclusive and exclusive criteria and any diagnosed co-morbidities: As mentioned, he had the typical DSM-5 symptoms, scoring 5/9 inattention and 9/9 hyperactivity-impulsivity symptoms which was well above the diagnostic threshold. There were no associated comorbidities.’9.Date of cessation of medication: The medication has not been ceased, and l consider that it will be necessary for several years yet while he completes his studies.11.Prognosis: l consider his prognosis to be good whichever way his ADHD goes. He may grow out of it over the next few years and not need medication. Or if it does continue, it is well controlled to the level where he functions normally.

Decision

Reasons for decision

The Tribunal must prioritise the safety of air navigation when assessing whether an individual should be awarded a Class 1 and Class 2 medical certificate (pursuant to s 9A(1) of the CA Act). The Tribunal has found that Mr Healy does not meet the medical standard for the issue of a Class 1 or Class 2 medical certificate. Having so found, the Tribunal has also determined that the extent to which Mr Healy fails to meet those standards is likely to endanger the safety of air navigation. Finally, having assessed the nature of the condition and the medicine used to control it, the Tribunal has determined that no conditions can be imposed that would ameliorate the threat posed to air safety by Mr Healy’s failure to meet the Class 1 and Class 2 medical standard.DECISION For the reasons outlined above, the Tribunal affirms the decision under review.

Ratio Decidendi

Legal Principle Established

By virtue of s 9A of the CA Act, CASA is required to regard the safety of air navigation as the most important consideration in the exercise of its powers and the performance of its functions. Furthermore, in accordance with regulation 67.015 of the CASR, a condition is "safety- relevant’’ if it is likely to reduce the ability of the person to exercise the privileges conferred by the licence.CONSIDERATION Overall, the Tribunal must undertake the following decision making process in determining whether Mr Healy should be granted a Class 1 or Class 2 medical certificate: a.determine whether Mr Healy meets the medical standards in Table 67.150 or 67.155 of the CASR. If the relevant standard is met, the certificate must be granted – r 67.180(1) and (2)(e);b.if Mr Healy does not meet the relevant medical standard, then the Tribunal must determine whether the extent to which Mr Healy fails the medical standard is likely to pose a risk to the safety of air navigation. If not, then the certificate may be granted – r 67.180(2)(e)(ii) and (f)(ii); andc.if the extent to which Mr Healy fails the medical standard is likely to endanger the safety of air navigation, then the certificate must be refused unless it can be issued with conditions which will ameliorate any risk posed – r 11.056.Does Mr Healy meet the class 1 and class 2 medical standards? In relation to this issue, CASA argued as follows in its Statement of Facts, Issues and Contentions:Established medical history31.The respondent contends that the available medical evidence supports the following findings:(a)in 2014, at the age of 27 years old, the applicant was diagnosed as having ADHD, which had been a life-long condition and was prescribed the stimulant, Dexamphetamine, 25mg controlled release capsules, one daily, and very occasional dexamphetamine 5mg tablets as a top up / alternative.(b)The applicant’s use of Dexamphetamine has assisted the applicant to improve his focus and general efficiency.(c)The applicant undertook two testing sessions by Dr Karen Booker, one whilst on medication, and another a week later having not taken his medication. The report dated 30 October 2016 with respect to these sessions indicated that the applicant’s fundamental intellectual abilities, as assessed by the WAIS-IV, and other cognitive skills appeared to be as expected for a man of his age.(d)On 21 February 2017, Dr Duke reported that the applicant does not appear to be symptom free when off medication, and that he continues to require the use of stimulant medication to control the symptoms of his ADHD.The medical standard32.In light of the above facts, the respondent contends that the applicant fails to meet the class 1 and class 2 medical standards in the following regard:1.he does not meet items 1.1(b) or 2.1(b) in that he has an established history of diagnosis for ADHD, which is a disability or disease (active or latent), which produces a degree of functional incapacity or risk of incapacitation:2.he does not meet items 1.3 or 2.3 in that he is prescribed, and continues to take, the stimulant Dexamphetamine for his condition, and this stimulant may cause the applicant to experience side effects which are likely to effect the applicant to an extent which is safety relevant.